Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Earl

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Cancer Research|October 12, 2011
RETRACTED: Cell-permeable NM23 blocks the maintenance and progression of established pulmonary metastasisJunghee Lim, Giyong Jang, Seeun Kang, et al.
Journal of Family Medicine and Primary Care|August 15, 2025
Polysomnographic evaluation of sleep quality and quantitative variables in patients of hypothyroidismManogna Ghantasala, Nitin A John, Madhuri Taranikanti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer†I A McNeish, J A Ledermann, L Webber, et al.
Frontiers in Plant Science|March 14, 2022
Modifying Anthocyanins Biosynthesis in Tomato Hairy Roots: A Test Bed for Plant Resistance to Ionizing Radiation and Antioxidant Properties in SpaceSilvia Massa, Riccardo Pagliarello, Alessia Cemmi, et al.
Science Advances|June 5, 2020
Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synucleinEunna Chung, Youngsil Choi, Jiae Park, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognosesH E Campbell, D Epstein, D Bloomfield, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2020
Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast CancerC Conefrey, J L Donovan, R C Stein, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 27, 2012
Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trialJ Bartlett, P Canney, A Campbell, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Cancer Research|October 12, 2011
RETRACTED: Cell-permeable NM23 blocks the maintenance and progression of established pulmonary metastasisJunghee Lim, Giyong Jang, Seeun Kang, et al.
Journal of Family Medicine and Primary Care|August 15, 2025
Polysomnographic evaluation of sleep quality and quantitative variables in patients of hypothyroidismManogna Ghantasala, Nitin A John, Madhuri Taranikanti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer†I A McNeish, J A Ledermann, L Webber, et al.
Frontiers in Plant Science|March 14, 2022
Modifying Anthocyanins Biosynthesis in Tomato Hairy Roots: A Test Bed for Plant Resistance to Ionizing Radiation and Antioxidant Properties in SpaceSilvia Massa, Riccardo Pagliarello, Alessia Cemmi, et al.
Science Advances|June 5, 2020
Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synucleinEunna Chung, Youngsil Choi, Jiae Park, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognosesH E Campbell, D Epstein, D Bloomfield, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2020
Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast CancerC Conefrey, J L Donovan, R C Stein, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 27, 2012
Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trialJ Bartlett, P Canney, A Campbell, et al.
Pageof 8